| 中文名稱:(±)14(15)-EET | 英文名稱:(±)14(15)-EET |
| CAS:197508-62-6 | 品牌: TargetMol |
| 產(chǎn)地: 美國 | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 產(chǎn)品類別: 抑制劑 | |
| 貨號: T35463 |
| 名稱 | (±)14(15)-EET |
| 描述 | (±)14(15)-EET is a metabolite of arachidonic acid that is formed via epoxidation of arachidonic acid by cytochrome P450.[1],[2] It prevents increases in leukotriene B4, ICAM-1, and chemokine (C-C motif) ligand 1 (CCL2) induced by oxidized LDL in primary rat pulmonary artery endothelial cells (RPAECs) when used at a concentration of 1 μM.[3] (±)14(15)-EET induces dilation of preconstricted isolated canine coronary arterioles (EC50 = 0.2 pM).[4] It reduces myocardial infarct size as a percentage of the area at risk in a canine model of ischemia-reperfusion injury induced by left anterior descending coronary artery (LAD) occlusion when administered at a dose of 0.128 mg/kg prior to occlusion or reperfusion.[5] |
| 存儲條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度 | Ethanol : >50 mg/mL (per Rao Maddipati), Sonication is recommended. DMF : >50 mg/mL (per Rao Maddipati), Sonication is recommended. DMSO : >50 mg/mL (per Rao Maddipati), Sonication is recommended. |
| 關(guān)鍵字 | 14,15-EpETrE | 14,15-EET | 14(15)-EET | (±)14(15)EET | (±)14(15) EET |
| 成立日期 | 2013-04-18 (14年) | 注冊資本 | 589.8595萬人民幣 |
| 員工人數(shù) | 100-500人 | 年營業(yè)額 | ¥ 1億以上 |
| 主營行業(yè) | 中間體,天然產(chǎn)物,生物化工,化學試劑,生物技術(shù)服務(wù) | 經(jīng)營模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
| 產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
|---|---|---|---|---|
| 詢價 |
VIP5年
|
武漢艾美捷科技有限公司
|
2026-07-27 | |
| 詢價 |
VIP4年
|
上海貝萬塔生物科技有限公司
|
2026-08-01 | |
| ¥1280 |
VIP1年
|
上海雙贏生物科技有限公司
|
2026-07-31 | |
| ¥1544.90 |
VIP14年
|
上海阿拉丁生化科技股份有限公司
|
2026-06-23 |